|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
It was reported to medtronic minimed that the customer reported high blood glucose and the change sensor alert.The customer reported a blood glucose value of 195 mg/dl.The customer reported hyperglycemia was treated with an insulin pump (subcutaneous insulin infusion) and assisted/self-treatment of severe glycemic excursion (major severity).The blood glucose was high for greater than 4 hours.The event involved products mmt-332a, mmt-1884, unomedical, and mmt-7040a.Troubleshooting was performed for the change sensor, and the customer is unable to run a transmitter test and/or test passed.Customer was advised to try another sensor.Troubleshooting was partially performed for high blood glucose, and the customer has been using the insulin pump system within 48 hours of the reported high blood glucose event.The customer was used the auto mode feature at the time of the event.No further patient complications were reported.No product return is required for mmt-332a, mmt-1884, unomedical, and mmt-7040a.
|